Statistics for Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
Total visits
views | |
---|---|
Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD) | 154 |
Total visits per month
views | |
---|---|
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
File Visits
views | |
---|---|
PHY2-8-e14434.pdf | 183 |
java.util.UUID:2aae191b-b953-4a7a-8623-68555307bdb5 | 51 |
java.util.UUID:222ca2cd-d5f3-45b4-b118-b76a8f3554a4 | 15 |
java.util.UUID:a9bc0ac4-a746-4afa-afb8-592648f7fc9b | 8 |
Top country views
views | |
---|---|
United States | 133 |
Canada | 2 |
Germany | 2 |
Ukraine | 2 |
China | 1 |
Malaysia | 1 |
Russia | 1 |
Sweden | 1 |
Top city views
views | |
---|---|
Wilmington | 49 |
Fairfield | 27 |
Cambridge | 9 |
Houston | 5 |
Ann Arbor | 4 |
Lakewood | 3 |
San Francisco | 3 |
Jacksonville | 2 |
Kiev | 2 |
Toronto | 2 |
Washington | 2 |
Zion | 2 |
Beijing | 1 |
Gunzenhausen | 1 |
Indianapolis | 1 |
Kansas City | 1 |
Kiez | 1 |
Kuala Lumpur | 1 |
Norwalk | 1 |
Seattle | 1 |
Stockholm | 1 |